GPT and hepatocellular carcinoma: In accordance with entire findings, further detailed analysis in the chronic patient group (CHB, LC, and HCC group) revealed significantly elevated liver parameters (ALT, AST, total and direct bilirubin) of the HDV-positive patients in comparison to HDV-negative patients (p<0.05) (Figure 4).